Holen Sie sich die Stockscreener-App
223.76
3.14%
6.49
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$217.27
Offen:
$221.705
24-Stunden-Volumen:
3.48M
Relative Volume:
0.31
Marktkapitalisierung:
$279.61B
Einnahmen:
$20.56B
Nettoeinkommen (Verlust:
$6.21B
KGV:
45.86
EPS:
4.8791
Netto-Cashflow:
$6.22B
1W Leistung:
-10.18%
1M Leistung:
+6.82%
6M Leistung:
+123.15%
1J Leistung:
+193.15%
1-Tages-Spanne:
$219.00
$225.12
1-Wochen-Bereich:
$215.79
$248.50
52-Wochen-Spanne:
$56.32
$256.68
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Compare LRCX vs ASML, AMAT, KLAC, TER
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
223.91 | 271.32B | 20.56B | 6.21B | 6.22B | 4.8791 |
|
ASML
Asml Holding Nv
|
1,397.81 | 524.53B | 36.97B | 10.86B | 12.49B | 27.95 |
|
AMAT
Applied Materials Inc
|
359.63 | 278.81B | 28.21B | 7.84B | 6.19B | 9.7629 |
|
KLAC
Kla Corp
|
1,469.28 | 188.93B | 12.74B | 4.56B | 4.38B | 34.42 |
|
TER
Teradyne Inc
|
305.83 | 47.63B | 3.19B | 554.05M | 450.41M | 3.483 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-29 | Hochstufung | Summit Insights | Hold → Buy |
| 2026-01-29 | Bestätigt | TD Cowen | Buy |
| 2026-01-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-23 | Bestätigt | TD Cowen | Buy |
| 2025-09-30 | Eingeleitet | HSBC Securities | Hold |
| 2025-09-29 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-22 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Fortgesetzt | Erste Group | Buy |
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
10,000 Shares in Lam Research Corporation $LRCX Bought by Strive Asset Management LLC - MarketBeat
Level Four Advisory Services LLC Sells 16,885 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corp (NASDAQ:LRCX) Exemplifies the Growth at a Reasonable Price (GARP) Strategy - ChartMill
Lam Research (LRCX) CFO awarded stock units, withholds shares for tax - Stock Titan
Lam Research (LRCX) SVP granted performance RSUs and stock, shares withheld for taxes - Stock Titan
Lam Research (LRCX) SVP reports equity grants and tax-withholding share disposals - Stock Titan
Lam Research (LRCX) CLO logs new stock awards and tax trades - Stock Titan
Lam Research (LRCX) SVP receives stock awards and tax-withheld shares - Stock Titan
Lam Research (LRCX) CEO receives major stock awards and tax withholdings - Stock Titan
Lam Research (LRCX) EVP has RSU shares withheld to cover taxes - Stock Titan
Lam Research Corp (LRCX) officer receives RSU awards and tax withholdings - Stock Titan
Fidelity lists planned LRCX common sales (NASDAQ: LRCX) on 03/02/2026 - Stock Titan
Lam Research Corp. stock underperforms Monday when compared to competitors - MarketWatch
Fidelity files Rule 144 notice for 4,000 LRCX shares (NASDAQ: LRCX) - Stock Titan
Ex-Dividend Reminder: PayPal Holdings, Lam Research and Old Dominion Freight Line - Nasdaq
How Is Lam Research’s Stock Performance Compared to Other Semiconductor Stocks? - FinancialContent
Lam Research Corp. Hits Day Low at $230.78 Amid Price Pressure - Markets Mojo
Lam Research stock price: LRCX drops as chip rally cools — here’s what could move it next - TechStock²
Lam Research Corporation $LRCX Stock Holdings Lessened by William Blair Investment Management LLC - MarketBeat
Morgan Stanley Raises Lam Research (LRCX) Valuation on Strong DRAM Investment Forecast - Finviz
Lam Research Corp. Hits New 52-Week High of $256.60 - Markets Mojo
Choreo LLC Has $4.54 Million Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Sold by West Family Investments Inc. - MarketBeat
LAM RESEARCH CORP (NASDAQ:LRCX) Embodies the Minervini Trend Template with Strong Fundamental Momentum - ChartMill
Banco Santander S.A. Purchases 41,322 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Applied Materials, Broadcom, Lam Research, Western Digital, and Allegro MicroSystems Shares Are Falling, What You Need To Know - Barchart.com
Lam Research Corp (LRCX) Shares Gap Down to $236.25 on Feb 26 - GuruFocus
Investors Heavily Search Lam Research Corporation (LRCX): Here is What You Need to Know - Yahoo Finance
Mitsubishi UFJ Asset Management Co. Ltd. Sells 63,305 Shares of Lam Research Corporation $LRCX - MarketBeat
Rep. Cleo Fields Buys Lam Research Corporation (NASDAQ:LRCX) Stock - MarketBeat
Lam Research Corp. stock outperforms competitors on strong trading day - MarketWatch
Lam Research (LRCX) CEO Timothy Archer makes bona fide gift of 7,080 shares - Stock Titan
Lam Research (NASDAQ:LRCX) Given New $254.00 Price Target at Morgan Stanley - MarketBeat
The Zacks Analyst Blog Highlights Costco Wholesale, Roche, Lam Research, Spruce Power and IDT - Nasdaq
Lam Research Corp Stock Opened Up by 3.04% on Feb 25: Drivers Behind the Movement - TradingKey
Lam Research stock reaches all-time high at 252.47 USD By Investing.com - Investing.com Nigeria
Lam Research stock reaches all-time high at 252.47 USD - Investing.com
Lam Research deepens investment in Boise to support projected growth in U.S. semiconductor manufacturing - dqindia.com
Top Stock Reports for Costco, Roche & Lam Research - Yahoo Finance
Lam Research Stock Near Records: Smart Buy or Peak AI Hype? - AD HOC NEWS
Lam Research Corp. Achieves 172.15% Return, Establishing It as a Multibagger Stock - Markets Mojo
GSA Capital Partners LLP Sells 5,398 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research (NASDAQ:LRCX) Stock Price Down 1.1%Here's Why - MarketBeat
Lam Research (LRCX) Expands Footprint Amid Industry Momentum - Finviz
Lam Research stock slides as tariff fog hits tech — what LRCX investors are watching next - Bez Kabli
Lam Research Deepens Investment in Boise, Idaho, to Support Projected Growth in U.S. Semiconductor Manufacturing - StorageNewsletter
Lam Research FY2026 EPS Estimate Raised by Erste Group Bank - MarketBeat
Lam Research stock price jumps into weekend; what to watch before Monday’s trade - Bez Kabli
Tredje AP fonden Takes Position in Lam Research Corporation $LRCX - MarketBeat
Trivest Advisors Ltd Takes $10.04 Million Position in Lam Research Corporation $LRCX - MarketBeat
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.47%
3.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):